|
|
| Phases of Development | Preclinical | Pilot | Phase I | Phase I/II | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Autoimmune | 4 | 0 | 0 | 0 | 3 | 1 | 0 | 1 | 0 | | Cancer | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Cardiovascular | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | | Dermatology | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Endocrine / Metabolic | 2 | 0 | 0 | 0 | 3 | 0 | 1 | 0 | 0 | | Inflammation | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | | Neurology | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Ophthalmic | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
|
|
Products Targeting Interleukin-1 (IL-1) beta